insights_auto
Bakit tumaas ang BMY 4.61%?
Tingnan ang Higit pang Detalyechevron_right
BMY:NYSE
Bristol-Myers Squibb Co
$59.28
arrow_upward
+4.61%(+2.61) 1D
$59.49
arrow_upward
+0.35% (+0.21)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 14, 4:00:04 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BMY...
Buksan
$56.81
Mataas
$59.38
Mababa
$56.58
Mkt. cap
121.09B
Avg. na dami
12.10M
Dami
14.05M
Dividend
4.25%
Bawat tatlong buwang dividend
$0.63
Petsa ng ex-dividend
Okt 2, 2026
P/E ratio
13.06
Mataas nang 52-wk
$68.64
Mababa nang 52-wk
$42.52
EPS
$4.54
Beta
0.19
Mga natitirang share
2.04B
Bilang ng mga empleyado
32K
Buksan
$56.81
Mataas
$59.38
Mababa
$56.58
Mkt. cap
121.09B
Avg. na dami
12.10M
Dami
14.05M
Dividend
4.25%
Bawat tatlong buwang dividend
$0.63
Petsa ng ex-dividend
Okt 2, 2026
P/E ratio
13.06
Mataas nang 52-wk
$68.64
Mababa nang 52-wk
$42.52
EPS
$4.54
Beta
0.19
Mga natitirang share
2.04B
Bilang ng mga empleyado
32K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
GuruFocus
·
1 oras ang nakalipas
Is Bristol-Myers Squibb Co (BMY) Overvalued After 4.6% Rally? GF
News Corp
·
2 oras ang nakalipas
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
MarketWatch
·
2 oras ang nakalipas
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
MarketBeat
·
3 oras ang nakalipas
Bristol Myers Squibb (NYSE:BMY) Shares Up 4% - What's Next?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Tungkol sa Bristol-Myers Squibb Co
CEOChris Boerner
Mga Empleyado32.5K
Itinatag1887
HeadquartersLungsod ng New York, New York, Estados Unidos
Sektor-
Websitebms.com